LINC00963 promotes metastasis in non–small-cell lung cancer (NSCLC) by stimulating the AKT/mTOR pathway and by inhibiting the ubiquitination of phosphoglycerate kinase 1 (PGK1) (Yu et al., 2017). Here, PGK1 is linked to lung cancer.